DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Furadantin (Nitrofurantoin) - Published Studies


Furadantin Related Published Studies

Well-designed clinical trials related to Furadantin (Nitrofurantoin)

One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2011.01]

One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. [2009.02]

Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. [2007.11.12]

A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. [2004.07]

Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. [2003.06.01]

[Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin] [2002.11]

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. [2002.09]

Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. [1999.11]

A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. [1999.03]

Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. [1997.06]

[Treatment of urinary tract infections with macro-crystalline nitrofurantoin] [1995.06]

A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. [1995.03]

A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. [1994.05]

Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. [1994.05]

Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. [1993.12.17]

Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study. [1992]

Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin. [1992]

Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women. [1991.10]

Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection. [1991.06]

Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study. [1990.12]

Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. [1990]

Pyelonephritis in pregnancy. The role of in-hospital management and nitrofurantoin suppression. [1987.12]

A comparative study of pipemidic acid and nitrofurantoin in the treatment of uncomplicated urinary tract infections. [1987.11.21]

Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin. [1987]

Well-designed clinical trials possibly related to Furadantin (Nitrofurantoin)

Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial. [2014]

Can a multifaceted educational intervention targeting both nurses and physicians change the prescribing of antibiotics to nursing home residents? A cluster randomized controlled trial. [2011.11]

Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. [2010.09.08]

The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO. [2009.09]

Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. [2005.07.27]

Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. [2005.07]

[Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study] [2004.01]

Laboratory aspects of asymptomatic bacteriuria in pregnancy. [2002.09]

[Antibiotic resistance of E coli isolated from healthy persons] [2001.09.03]

Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. [1999.05]

In vitro susceptibility of new generation of antibacterial antibiotics against pathogenic bacteria. [1999.02]

Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. [1995.04]

Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. [1995.01.04]

Antibiotic prophylaxis following lower urinary tract instrumentation. [1992.06]

Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement. [1991.08]

Bacteriuria in the puerperium. Risk factors, screening procedures, and treatment programs. [1990.03]

Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection. [1990]

Prevention of catheter-associated gram-negative bacilluria with norfloxacin by selective decontamination of the bowel and high urinary concentration. [1989.06]

Treatment of bacterial infections of the female urinary tract by immunization of the patients. [1987]

Other research related to Furadantin (Nitrofurantoin)

Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. [2011.06]

[Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults]. [2010.10]

Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate. [2010.09]

One Week of Nitrofurantoin Before Percutaneous Nephrolithotomy Significantly Reduces Upper Tract Infection and Urosepsis: A Prospective Controlled Study. [2010.06.08]

Neurogenic bladder: a complication after endoscopic adhesiolysis with return of bladder function while using nitrofurantoin. [2010.05.01]

Nitrofurantoin pulmonary toxicity: neglected threat. [2010.04]

Acute renal failure from nitrofurantoin-induced acute granulomatous interstitial nephritis. [2010.01]

Probable nitrofurantoin-induced bronchiolitis obliterans with organizing pneumonia. [2009.11.01]

Effect of pregnancy on nitrofurantoin disposition in mice. [2009.11]

Nitrofurantoin-induced systemic inflammatory response syndrome. [2009.10]

Nitrofurantoin-induced acute liver damage in pregnancy. [2009.09]

[Rapid resolution of nitrofurantoin-induced interstitial lung disease] [2009.07]

DRESS syndrome caused by nitrofurantoin. [2009.04]

Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice. [2009]

Nitrofurantoin: the return of an old friend in the wake of growing resistance. [2008.12]

N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk. [2008.12]

Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case. [2008.09]

The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. [2008.08]

Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: high-resolution computed tomography findings. [2008.03]

[Nitrofurantoin-induced lung disease: about two cases] [2008.02]

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. [2008.01]

Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. [2007.12]

Nitrofurantoin neuropathy: a forgotten adverse effect. [2007.08]

Nitrofurantoin-induced lung- and hepatotoxicity. [2007.04]

Severe nitrofurantoin lung disease resolving without the use of steroids. [2007.04]

[Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus] [2007]

[Efficacy of nitrofurantoin in the treatment of chronic urinary tract infections in patients with type 2 diabetes mellitus] [2006.11]

New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. [2006.11]

[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?] [2006.10]

Giant cell interstitial pneumonia associated with nitrofurantoin. [2006.05]

Recurrent acute nitrofurantoin-induced pulmonary toxicity. [2006.05]

Chronic nitrofurantoin-induced lung disease. [2005.10]

Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay. [2005.07]

Piperitone from Mentha longifolia var. chorodictya Rech F. reduces the nitrofurantoin resistance of strains of enterobacteriaceae. [2004.11]

Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. [2004.08]

Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. [2004.08]

Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment. [2004.04]

[Liver cirrhosis due to chronic use of nitrofurantoin] [2004.01.31]

Nitrofurantoin-induced chronic active hepatitis. [2002.03]

Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantoin for recurrent urinary tract infection. [2002.01]

Active transport of nitrofurantoin into human milk. [2001.06]

The establishment of conditions to efficiently screen photosynthesis-deficient mutants of Synechocystis sp. PCC 6803 by nitrofurantoin treatment. [2001.04]

Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. [2001.04]

Nitrofurantoin and congenital abnormalities. [2001.03]

Protection against nitrofurantoin-induced oxidative stress by coelenterazine analogues and their oxidation products in rat hepatocytes. [2001.03]

Active transport of nitrofurantoin into rat milk. [2001]

Ocular myasthenia and nitrofurantoin. [2000.10]

Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice. [2000.10]

[Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy] [2000.07]

A new in vitro/in vivo kinetic correlation method for nitrofurantoin matrix tablet formulations. [2000.07]

Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities. [2000.03]

Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin. [2000.03]

[Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998] [1999.11.29]

Transient acute renal failure due to nitrofurantoin poisoning. [1999.11]

Design and biopharmaceutical evaluation of nitrofurantoin-loaded Eudragit RS100 micropellets. [1999.08]

Preparation and biopharmaceutical evaluation of nitrofurantoin loaded Eudragit RS100 and Eudragit RL 100 micropellets. [1999.05]

Nitrofurantoin-induced immune-mediated lung and liver disease. [1999.05]

Nitrofurantoin-associated Sweet's syndrome. [1999.03]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017